Chinese names like Alibaba and ACM Research have room to catch up while valuations elsewhere get absolutely out of hand. Per @negligible_cap, Cerebras is targeting up to $4B in its US IPO at a $40B valuation. The China catch-up trade is obvious, yet still non-consensus. x.com
